Tarsus Pharmaceuticals (TARS) Other Working Capital Changes (2019 - 2022)

Tarsus Pharmaceuticals' Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$1000.0 for Q2 2024.

• On a quarterly basis, Other Working Capital Changes rose 96.55% year-over-year to -$1000.0 in Q2 2024; TTM through Mar 2025 was -$1000.0, a 97.44% increase from a year earlier, with the FY2024 full-year figure at -$233000.0, down 225.95% from the prior year.
• Other Working Capital Changes climbed to -$1000.0 in Q2 2024 per TARS's latest filing, from -$232000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $1.4 million in Q4 2021 and bottomed at -$926000.0 in Q1 2022.
• The 4-year median for Other Working Capital Changes is $321000.0 (2021), against an average of $434363.6.
• Across the five-year window, Other Working Capital Changes jumped 2600.0% in 2023 and plunged 2800.0% in 2024, its largest moves.
• Year by year, Other Working Capital Changes stood at -$35000.0 in 2021, then surged by 120.0% to $7000.0 in 2022, then soared by 2600.0% to $189000.0 in 2023, then tumbled by 100.53% to -$1000.0 in 2024.
• Per Business Quant, the three latest TARS Other Working Capital Changes figures stand at -$1000.0 (Q2 2024), -$232000.0 (Q1 2024), and $189000.0 (Q4 2023).